AHRQ Requests Information to Develop Health IT-Enabled Quality Measures
requested information from the public regarding current successful strategies and challenges regarding quality measurement-enabled health information technology.
AHRQ is seeking information to guide the development of HIT-enabled quality measure development and reporting because HIT has the potential to advance quality measurement and reporting through the use of efficient automated data collection, analysis, processing and its ability to facilitate information exchange among and across care settings, providers and patients. AHRQ's questions include:
1. Briefly describe what motivates your interest in clinically-informed quality measures through health information technology. To what extent is your interest informed by a particular role in this area?
2. Whose voices are not being heard or effectively engaged at the crucial intersection of health IT and quality measurement? What non-regulatory approaches could facilitate enhanced engagement of these parties?
3. Some quality measures of interest have been more difficult to generate, such as measures of greater interest to consumers, measures to assess value, specialty-specific measures, measures across care settings and measures that take into account variations in risk. Describe the infrastructure that would be needed to ensure development of such measures.
To view all of AHRQ's questions and submit a response, click here. The deadline is Aug. 20.
More Articles on HIT:Mobile Health: Why Physicians, Hospitals Should Overcome Reluctance
12 Reasons Why Hospitals Pay More for IT Than Other Industries
4 Factors for Choosing An Encrypted Text Messaging Service For Your Healthcare Organization
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.